BIOLOGICAL · Unmapped registry intervention
UniCAR02-T (IMP) With Targeting Module TM123
Find medicine records ·
Find other trials using this name
Clinical trial
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
NCT07474051
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
UniCAR02-T-pPSMA
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Allo-RevCAR01- T with Targeting Module R-TM123
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Allo-QuadCAR01-T
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedLong-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Design: OBSERVATIONAL · Status: ENROLLING BY INVITATION · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
AML (Acute Myelogenous Leukemia)unresolved
Prostate Cancerverified · MONDO: prostate cancer
Interventions
UniCAR02-T-pPSMABIOLOGICAL
Allo-QuadCAR01-TBIOLOGICAL
Sponsors & collaborators
AvenCell Therapeutics, Inc.lead sponsor
AvenCell Europe GmbHcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07474051 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.